Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Polyglutamate Paclitaxel Compared With Docetaxel in Treating Patients With Progressive Non-Small Cell Lung Cancer

The recruitment status of this study is unknown because the information has not been verified recently.
Verified July 2013 by CTI BioPharma.
Recruitment status was  Active, not recruiting
Information provided by (Responsible Party):
CTI BioPharma Identifier:
First received: February 5, 2003
Last updated: July 29, 2013
Last verified: July 2013
No Study Results Posted on for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)